Adicet Bio (NASDAQ:ACET) Upgraded at StockNews.com

StockNews.com upgraded shares of Adicet Bio (NASDAQ:ACET – Free Report) to a sell rating in a research report sent to investors on Friday. ACET has been the subject of several other reports. Canaccord Genuity Group reaffirmed a buy rating and issued a $19.00 price target on shares of Adicet Bio in a research note on […]

Related Keywords

Adicet Bio , Sei Investments Co , Canaccord Genuity Group , Adicet Bio Company Profile , Vanguard Group Inc , Orbimed Advisors Llc , Adicet Bio Inc , Nuveen Asset Management , Barclays Plc , Free Report , Genuity Group , Get Free Report , Director Orbimed Advisors Llc , Asset Management , Sei Investments , Adicet Bio Daily ,